The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
Open accessAbstract
Amplification of downstream signaling by AXL receptor tyrosine kinase alters the migratory response of breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Book Review: Pattern Recognition and Machine Learning
Nasrabadi, N. M. (2007) · Journal of Electronic Imaging · doi:10.1117/1.2819119 · Cited by 22,066
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
A leisurely look at the bootstrap, the jackknife, and cross-validation
Efron, B., & Gong, G. (1983) · The American Statistician · doi:10.1080/00031305.1983.10483087 · Cited by 3,229
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhang, Z., Lee, J. C., Lin, L., Olivas, V., Au, V., LaFramboise, T., Abdel-Rahman, M., Wang, X., Levine, A. D., Rho, J. K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2330 · Cited by 1,224
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Wilson, T. R., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., et al. (2012) · Nature · doi:10.1038/nature11249 · Cited by 1,134 · cited 4×
“Because activation of alternative receptors is a widespread means of resistance to RTKtargeted inhibitors (3, 4), we used the Cancer Cell Line Encyclopedia (CCLE), a publicly available data set of expression and drug response (38), to examine whether combinatorial expression of multiple RTKs may be related to lack of…”
BackgroundMethodInfluentialByers, L. A., Diao, L., Wang, J., Saintigny, P., Girard, L., Peyton, M., Shen, L., Fan, Y., Giri, U., Tumula, P. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1558 · Cited by 1,059
BioNumbers—the database of key numbers in molecular and cell biology
Milo, R., Jorgensen, P., Moran, U., Weber, G., & Springer, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp889 · Cited by 1,055
Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., Hartwell, K., Onder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004900107 · Cited by 1,041
The ERBB network: at last, cancer therapy meets systems biology
Yarden, Y., & Pines, G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3309 · Cited by 988
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Arumugam, T., Ramachandran, V., Fournier, K. F., Wang, H., Marquis, L., Abbruzzese, J. L., Gallick, G. E., Logsdon, C. D., McConkey, D. J., & Choi, W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2819 · Cited by 863
Aktas, B., Tewes, M., Fehm, T., Hauch, S., Kimmig, R., & Kasimir-Bauer, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2333 · Cited by 736
Lee, M. J., Ye, A. S., Gardino, A. K., Heijink, A. M., Sorger, P. K., MacBeath, G., & Yaffe, M. B. (2012) · Cell · doi:10.1016/j.cell.2012.03.031 · Cited by 680
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
Gjerdrum, C., Tiron, C., Høiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Li, S., McCormack, E., Gjertsen, B. T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909333107 · Cited by 594
Holland, S. J., Pan, A., Franci, C., Hu, Y., Chang, B., Li, W., Duan, M., Torneros, A., Yu, J., Heckrodt, T. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2997 · Cited by 550
Tannock, I. F., Lee, C. M., Tunggal, J. K., Cowan, D., & Egorin, M. J. (2002) · PubMed · Cited by 505
Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL
Liu, L., Greger, J., Shi, H., Liu, Y., Greshock, J., Annan, R., Halsey, W., Sathe, G. M., Martin, A.-M., & Gilmer, T. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4490 · Cited by 495
Shapiro, I. M., Cheng, A. W., Flytzanis, N. C., Balsamo, M., Condeelis, J. S., Oktay, M. H., Burge, C. B., & Gertler, F. B. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002218 · Cited by 461
Self-citationChaft, J. E., Oxnard, G. R., Sima, C. S., Kris, M. G., Miller, V. A., & Riely, G. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1468 · Cited by 418
Huang, P. H., Mukasa, A., Bonavia, R., Flynn, R. A., Brewer, Z. E., Cavenee, W. K., Furnari, F. B., & White, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705158104 · Cited by 390
Nagane, M., Levitzki, A., Gazit, A., Cavenee, W. K., & Huang, H.-J. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5724 · Cited by 363
Li, Q.-Q., Xu, J.-D., Wang, W.-J., Cao, X.-X., Chen, Q., Tang, F., Chen, Z.-Q., Liu, X.-P., & Xu, Z.-D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2372 · Cited by 338
Shiozawa, Y., Pedersen, E. A., Patel, L. R., Ziegler, A. M., Havens, A. M., Jung, Y., Wang, J., Zalucha, S., Loberg, R. D., Pienta, K. J., et al. (2010) · Neoplasia · doi:10.1593/neo.91384 · Cited by 314
A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo
Martens, T., Schmidt, N.-O., Eckerich, C., Fillbrandt, R., Merchant, M., Schwall, R., Westphal, M., & Lamszus, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1418 · Cited by 305
Li, Y., Ye, X., Tan, C., Hongo, J. A., Zha, J., Liu, J., Kallop, D., Ludlam, M. J. C., & Pei, L. (2009) · Oncogene · doi:10.1038/onc.2009.212 · Cited by 288
Riely, G. J., Kris, M. G., Zhao, B., Akhurst, T., Milton, D. T., Moore, E., Tyson, L., Pao, W., Rizvi, N. A., Schwartz, L. H., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0560 · Cited by 287
Bias of the corrected AIC criterion for underfitted regression and time series models
HURVICH, C. M., & TSAI, C.-L. (1991) · Biometrika · doi:10.1093/biomet/78.3.499 · Cited by 285
Hutterer, M., Knyazev, P., Abate, A., Reschke, M., Maier, H., Stefanova, N., Knyazeva, T., Barbieri, V., Reindl, M., Muigg, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0862 · Cited by 280
Expression of Axl in Lung Adenocarcinoma and Correlation with Tumor Progression
Shinh, Y.-S., Lai, C.-Y., Kao, Y.-R., Shiah, S.-G., Chu, Y.-W., Lee, H.-S., & Wu, C.-W. (2005) · Neoplasia · doi:10.1593/neo.05640 · Cited by 273
Frederick, B. A., Helfrich, B. A., Coldren, C. D., Zheng, D., Chan, D., Bunn, P. A., & Raben, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0138 · Cited by 270
Ye, X., Li, Y., Stawicki, S., Couto, S., Eastham-Anderson, J., Kallop, D., Weimer, R., Wu, Y., & Pei, L. (2010) · Oncogene · doi:10.1038/onc.2010.268 · Cited by 232
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
Ercan, D., Zejnullahu, K., Yonesaka, K., Xiao, Y., Capelletti, M., Rogers, A., Lifshits, E., Brown, A., Lee, C., Christensen, J. G., et al. (2010) · Oncogene · doi:10.1038/onc.2009.526 · Cited by 228
Jin, H., Yang, R., Zheng, Z., Romero, M., Ross, J., Bou-Reslan, H., Carano, R. A. D., Kasman, I., Mai, E., Young, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5960 · Cited by 220
A systems view of epithelial–mesenchymal transition signaling states
Thomson, S., Petti, F., Sujka-Kwok, I., Mercado, P., Bean, J., Monaghan, M., Seymour, S. L., Argast, G. M., Epstein, D. M., & Haley, J. D. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9367-3 · Cited by 211
Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
Zhuang, G., Brantley-Sieders, D. M., Vaught, D., Yu, J., Xie, L., Wells, S., Jackson, D., Muraoka-Cook, R., Arteaga, C., & Chen, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1845 · Cited by 208
Mark, M. R., Chen, J., Hammonds, R. G., Sadick, M., & Godowsk, P. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9785 · Cited by 206
Koorstra, J.-B. M., Karikari, C., Feldmann, G., Bisht, S., Leal-Rojas, P., Offerhaus, G. J. A., Alvarez, H., & Maitra, A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.7.7923 · Cited by 205
Thomson, S., Petti, F., Sujka-Kwok, I., Epstein, D., & Haley, J. D. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9200-4 · Cited by 190
Roussos, E. T., Balsamo, M., Alford, S. K., Wyckoff, J. B., Gligorijevic, B., Wang, Y., Pozzuto, M., Stobezki, R., Goswami, S., Segall, J. E., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.086231 · Cited by 184
Self-citationAxl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
Tai, K.-Y., Shieh, Y.-S., Lee, C.-S., Shiah, S.-G., & Wu, C.-W. (2008) · Oncogene · doi:10.1038/onc.2008.57 · Cited by 168
Targeting Axl With an High-affinity Inhibitory Aptamer
Cerchia, L., Esposito, C. L., Camorani, S., Rienzo, A., Stasio, L., Insabato, L., Affuso, A., & de Franciscis, V. (2012) · Molecular Therapy · doi:10.1038/mt.2012.163 · Cited by 159
Receptor tyrosine kinases expressed in metastatic colon cancer
Craven, R. J., Xu, L., Weiner, T. M., Fridell, Y.-W. C., Dent, G. A., Srivastava, S., Varnum, B. C., Liu, E. T., & Cance, W. G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600611 · Cited by 146
Overexpression of Protein Tyrosine Kinases in Human Esophageal Cancer
Nemoto, T., Ohashi, K., Akashi, T., Johnson, J. D., & Hirokawa, K. (2008) · Pathobiology · doi:10.1159/000164123 · Cited by 130
HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors
Gusenbauer, S., Vlaicu, P., & Ullrich, A. (2012) · Oncogene · doi:10.1038/onc.2012.396 · Cited by 128
Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
Lapuk, A. V., Marr, H., Jakkula, L. R., Pedro, H., Bhattacharya, S., Purdom, E. A., Hu, Z., Simpson, K., Pachter, L. S., Durinck, S., et al. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0528 · Cited by 119
Harbinski, F., Craig, V. J., Sanghavi, S., Jeffery, D. A., Liu, L., Sheppard, K. A., Wagner, S., Stamm, C., Buneß, A., Chatenay‐Rivauday, C., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0237 · Cited by 114
Berclaz, G., Altermatt, H. J., Rohrbach, V., Kieffer, I., Dreher, E. F., & Andres, A. ‐. (2001) · Annals of Oncology · doi:10.1023/a:1011126330233 · Cited by 107
The role of γ-carboxylation in the anti-apoptotic function of gas6
Hasanbasic, I., Rajotte, I., & Blostein, M. D. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01662.x · Cited by 99
2D protrusion but not motility predicts growth factor–induced cancer cell migration in 3D collagen
Meyer, A. S., Hughes, S. K., Kay, J. E., Castillo, A., Wells, A. H., Gertler, F. B., & Lauffenburger, D. A. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201201003 · Cited by 96
Self-citationHafizi, S., Alindri, F., Karlsson, R., & Dahlbäck, B. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02718-3 · Cited by 88
Yeh, C.-Y., Shin, S.-M., Yeh, H.-H., Wu, T.-J., Shin, J.-W., Chang, T., Raghavaraju, G., Lee, C., Chiang, J.-H., Tseng, V. S. M., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-139 · Cited by 77
Pop, O., Pirvu, A., Toffart, A., & Moro‐Sibilot, D. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318257fc1d · Cited by 63
Kim, H., Meyer, A. S., Wagner, J. P., Hughes, S. K., Wells, A. H., Gertler, F. B., & Lauffenburger, D. A. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.008433 · Cited by 30
Self-citation
Cited by
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Graham, D. K., DeRyckere, D., Davies, K. D., & Earp, H. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3847 · Cited by 698
Zhu, C., Wei, Y., & Wei, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1090-3 · Cited by 488
Diversification of TAM receptor tyrosine kinase function
Zagórska, A., Través, P. G., Lew, E. D., Dransfield, I., & Lemke, G. (2014) · Nature Immunology · doi:10.1038/ni.2986 · Cited by 430
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Taniguchi, H., Yamada, T., Wang, R., Tanimura, K., Adachi, Y., Nishiyama, A., Tanimoto, A., Takeuchi, S., Araujo, L. H., Boroni, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08074-0 · Cited by 356
The dynamic control of signal transduction networks in cancer cells
Kolch, W., Halasz, M., Granovskaya, M., & Kholodenko, B. N. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3983 · Cited by 339
Metadata
- Authors
- Meyer, A. S., Miller, M. A., Gertler, F. B., & Lauffenburger, D. A.
- Venue
- Science Signaling
- Published
- 2013-08-06
- Volume
- 6
- Issue
- 287
- Pages
- ra66-ra66
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- OpenAlex
- W1576368899
- Cited by
- 284
- References
- 59
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.